PE20030732A1 - Empleo de alquilfosfocolinas en el tratamiento preventivo de enfermedades causadas por protozoarios - Google Patents
Empleo de alquilfosfocolinas en el tratamiento preventivo de enfermedades causadas por protozoariosInfo
- Publication number
- PE20030732A1 PE20030732A1 PE2003000061A PE2003000061A PE20030732A1 PE 20030732 A1 PE20030732 A1 PE 20030732A1 PE 2003000061 A PE2003000061 A PE 2003000061A PE 2003000061 A PE2003000061 A PE 2003000061A PE 20030732 A1 PE20030732 A1 PE 20030732A1
- Authority
- PE
- Peru
- Prior art keywords
- diseases caused
- protozoarians
- alkylphosphocolins
- treatment
- preventive treatment
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000003449 preventive effect Effects 0.000 title 1
- 208000004554 Leishmaniasis Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000001142 anti-diarrhea Effects 0.000 abstract 1
- 230000003474 anti-emetic effect Effects 0.000 abstract 1
- 239000002111 antiemetic agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO EN MAMIFEROS, DE ENFERMEDADES CAUSADAS POR PROTOZOARIOS, EN PARTICULAR LEISHMANIASIS, LA CUAL CONTIENE a)ALQUILFOSFOCOLINA, EN PARTICULAR HEXADECILFOSFOCOLINA (MILTEFOSINA) o FOSFATO DE OCTADECIL-(1,1-DIMETIL-PIPERIDINIO-4-ILO) (PERIFOSINA); b)UN ANTIEMETICO Y/O UN ANTIDIARREICO. SE REFIERE TAMBIEN AL EMPLEO DE ALQUILFOSFOCOLINAS PARA LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO YA DESCRITO Y A UN ESQUEMA DE DOSIFICACION DE LA COMPOSICION PARA DICHO TRATAMIENTO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10203195A DE10203195A1 (de) | 2002-01-25 | 2002-01-25 | Verwendung von Alkylphosphocholinen in der Präventivbehandlung von Protozoenerkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030732A1 true PE20030732A1 (es) | 2003-09-27 |
Family
ID=7713213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000061A PE20030732A1 (es) | 2002-01-25 | 2003-01-20 | Empleo de alquilfosfocolinas en el tratamiento preventivo de enfermedades causadas por protozoarios |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1467742A1 (es) |
| JP (1) | JP2005515244A (es) |
| CN (1) | CN1622811A (es) |
| AR (1) | AR038224A1 (es) |
| AU (1) | AU2003236787B2 (es) |
| BR (1) | BR0307021A (es) |
| CA (1) | CA2470185A1 (es) |
| CO (1) | CO5601024A2 (es) |
| DE (1) | DE10203195A1 (es) |
| IL (2) | IL162492A0 (es) |
| MX (1) | MXPA04007193A (es) |
| NZ (1) | NZ548040A (es) |
| PE (1) | PE20030732A1 (es) |
| TW (1) | TWI339582B (es) |
| WO (1) | WO2003061669A1 (es) |
| ZA (1) | ZA200404690B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT501545B1 (de) * | 2005-02-23 | 2007-10-15 | Obwaller Andreas Dr | Reinigungsmittel für kontaktlinsen |
| WO2007071658A2 (en) * | 2005-12-19 | 2007-06-28 | Æterna Zentaris Gmbh | Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof |
| EP1800684A1 (en) * | 2005-12-20 | 2007-06-27 | Zentaris GmbH | Novel alkyl phospholipid derivatives and uses thereof |
| CN104473941A (zh) * | 2014-12-20 | 2015-04-01 | 长沙佰顺生物科技有限公司 | 一种含有米替福新的药物制剂及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4132345A1 (de) * | 1991-09-27 | 1993-04-01 | Max Planck Gesellschaft | Ether-lysolecithine und alkylphosphocholine in liposomen |
| DE4132344A1 (de) * | 1991-09-27 | 1993-04-01 | Max Planck Gesellschaft | Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis |
| ATE202701T1 (de) * | 1992-03-06 | 2001-07-15 | Lica Pharmaceuticals As | Behandlung und prophylaxe von durch parasiten oder bakterien verursachten erkrankungen |
| AU756805B2 (en) * | 1998-01-22 | 2003-01-23 | Zentaris Gmbh | Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
| DE10020812C2 (de) * | 2000-04-20 | 2003-06-26 | Robert Koch Inst | Verwendung von Naphthindazol-4,9-chinonen als Antiparasitika |
| AU2002232400A1 (en) * | 2000-11-06 | 2002-05-15 | U.S. Army Medical Research And Materiel Command | Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis |
-
2002
- 2002-01-25 DE DE10203195A patent/DE10203195A1/de not_active Withdrawn
-
2003
- 2003-01-07 EP EP03731619A patent/EP1467742A1/de not_active Ceased
- 2003-01-07 MX MXPA04007193A patent/MXPA04007193A/es active IP Right Grant
- 2003-01-07 IL IL16249203A patent/IL162492A0/xx unknown
- 2003-01-07 NZ NZ548040A patent/NZ548040A/en not_active IP Right Cessation
- 2003-01-07 WO PCT/EP2003/000072 patent/WO2003061669A1/de not_active Ceased
- 2003-01-07 CN CNA038027062A patent/CN1622811A/zh active Pending
- 2003-01-07 CA CA002470185A patent/CA2470185A1/en not_active Abandoned
- 2003-01-07 AU AU2003236787A patent/AU2003236787B2/en not_active Expired
- 2003-01-07 JP JP2003561613A patent/JP2005515244A/ja active Pending
- 2003-01-07 BR BR0307021-2A patent/BR0307021A/pt not_active Application Discontinuation
- 2003-01-13 TW TW092100614A patent/TWI339582B/zh not_active IP Right Cessation
- 2003-01-20 PE PE2003000061A patent/PE20030732A1/es not_active Application Discontinuation
- 2003-01-24 AR ARP030100214A patent/AR038224A1/es unknown
-
2004
- 2004-06-14 ZA ZA200404690A patent/ZA200404690B/en unknown
- 2004-06-14 IL IL162492A patent/IL162492A/en active IP Right Grant
- 2004-07-23 CO CO04070642A patent/CO5601024A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL162492A0 (en) | 2005-11-20 |
| DE10203195A1 (de) | 2003-08-07 |
| NZ548040A (en) | 2007-06-29 |
| MXPA04007193A (es) | 2004-10-29 |
| CA2470185A1 (en) | 2003-07-31 |
| ZA200404690B (en) | 2004-09-27 |
| TW200302103A (en) | 2003-08-01 |
| TWI339582B (en) | 2011-04-01 |
| BR0307021A (pt) | 2004-11-03 |
| CN1622811A (zh) | 2005-06-01 |
| WO2003061669A1 (de) | 2003-07-31 |
| IL162492A (en) | 2009-12-24 |
| AU2003236787B2 (en) | 2007-03-22 |
| JP2005515244A (ja) | 2005-05-26 |
| EP1467742A1 (de) | 2004-10-20 |
| CO5601024A2 (es) | 2006-01-31 |
| AR038224A1 (es) | 2005-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| BRPI0418251B8 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
| AR047841A1 (es) | Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios | |
| CY1116464T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| PE20040751A1 (es) | COMPOSICION FARMACEUTICA QUE COMPRENDE DOSIS BAJAS DE UN INHIBIDOR DEL TNFalfa HUMANO | |
| ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
| AR037109A1 (es) | Uso de flibanserina | |
| DOP2002000429A (es) | Imidazotriazinas | |
| HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
| IS8485A (is) | Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki | |
| EA200400664A1 (ru) | Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii | |
| AR109263A2 (es) | Composición que comprende moxidectina | |
| UY27296A1 (es) | Composición farmacéutica que contiene mosaprida y pancreatina | |
| ATE499939T1 (de) | Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| BR9916575A (pt) | Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa | |
| EP1781277A4 (en) | COMBINATION PREPARATION | |
| ES2340502T3 (es) | Compuestos de 1,4,8-triazaespiro(4,5)decan-2-ona sustituidos para el tratamiento de la obesidad. | |
| CO5190674A1 (es) | Tratamiento de desordenes neuroticos desordenes neuroticos | |
| EA200501821A1 (ru) | Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат | |
| EA200500764A1 (ru) | Фармацевтические композиции и лекарственные формы для трансбуккальной и сублингвальной доставки тизанидина и способы введения тизанидина сублингвально или трансбуккально | |
| CL2004000765A1 (es) | Composicion farmaceutica intranasal que comprende un compuesto derivado de 8,9-dioxo-2,6-diazabiciclo. | |
| PE20030732A1 (es) | Empleo de alquilfosfocolinas en el tratamiento preventivo de enfermedades causadas por protozoarios | |
| MX9403032A (es) | Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos. | |
| SE0000303D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |